諾德股份(600110.SH):擬向特定對象發行不超3.4億股認購股份
格隆匯6月7日丨諾德股份(600110.SH)公吿,公司第九屆董事會第四十次會議審議通過了《關於公司2021年度非公開發行股票方案的議案》《關於公司與認購對象簽署附條件生效的股份認購協議的議案》等議案。公司擬向深圳市邦民產業控股有限公司、深圳市弘源新材料有限公司、深圳邦民新材料有限公司等3名特定對象非公開發行不超過3.4億股(含本數,下同)普通股股票(“本次非公開發行”或“本次發行”)。
2021年6月7日,公司作為甲方與乙方深圳市邦民產業控股有限公司、深圳市弘源新材料有限公司及深圳邦民新材料有限公司分別簽署了附條件生效的股份認購協議。據此,乙方擬認購股份合計3.4億股,認購金額合計22.88億元。非公開發行股票的價格為6.73元/股。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.